Skip to main content
. Author manuscript; available in PMC: 2014 May 7.
Published in final edited form as: J Nucl Med. 2011 May 13;52(6):934–941. doi: 10.2967/jnumed.110.086777

Table 3. Radiation-Absorbed Dose Estimates (mSv/MBq) for 18F-PEG6-IPQA.

Target organ Adult female model using female residence times Adult male model using male residence times Adult male model using average residence times
Adrenals 2.03E02 1.45E–02 1.55E–02
Brain 6.36E–203 5.70E–03 5.64E–3
Breasts 7.96E–03 7.74E–03 7.12E–03
Gallbladder wall 5.79E–01 2.53E–01 3.94E–01
Heart wall 1.48E–02 1.28E–02 1.25E–02
Kidneys 1.23E–01 4.67E–02 8.30E–02
Liver 6.03E–02 3.86E–02 4.29E–02
Lower large intestine wall 1.48E–02 1.55E–02 1.45E–02
Lungs 1.76E–02 1.16E–02 1.27E–02
Muscle 1.07E–02 1.03E–02 9.73E–03
Osteogenic cells 1.52E–02 1.45E–02 1.34E–02
Ovaries 1.79E–02
Pancreas 2.21E–02 1.64E–02 1.78E–02
Red marrow 1.20E–02 1.13E–02 1.12E–02
Skin 7.17E–03 7.32E–03 6.70E–03
Small intestine 7.14E–02 8.14E–02 8.16E–02
Spleen 1.50E–02 1.19E–02 1.21E–02
Stomach wall 1.59E–02 1.35E–02 1.34E–02
Testes 8.80E–03 7.78E–03
Thymus 9.43E–03 9.19E–03 8.34E–03
Thyroid 7.56E–03 8.72E–03 7.68E–03
Upper large intestine wall 2.87E–02 2.58E–02 2.67E–02
Urinary bladder wall 2.50E–02 2.25E–02 2.16E–02
Uterus 1.71E–02 1.82E–02 1.73E–02
Total body 1.33E–02 1.20E–02 1.17E–02
Effective dose equivalent 6.16E–02 3.60E–02 4.67E–02
Effective dose 1.97E–02 1.57E–02 1.65E–02